Charles Walker, MD
Surgery · Bainbridge, GANPI 1154389369
Payments from drug & device makers
Across 81 payments — averaging $18.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$273
- Organogenesis Inc.$271
- Misonix Inc$124
- Elucent Medical$122
- Olympus America Inc.$88
- Novo Nordisk$75
- plus $573 from 19 others
What the payments were for
- Food & beverage$1,49998%
- Entertainment$272%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 15 | $273 |
| Organogenesis Inc. | 12 | $271 |
| Misonix Inc | 12 | $124 |
| Elucent Medical | 1 | $122 |
| Olympus America Inc. | 3 | $88 |
| Novo Nordisk | 4 | $75 |
| Kerecis Limited | 4 | $74 |
| Integra Lifesciences Corporation | 5 | $65 |
| AstraZeneca | 2 | $50 |
| Johnson & Johnson(2 entities) | 3 | $42 |
| KCI USA, Inc. | 2 | $36 |
| Corcept Therapeutics | 2 | $36 |
| Avanir Pharmaceuticals, Inc. | 2 | $32 |
| Lilly USA, LLC | 2 | $32 |
| Exact Sciences | 1 | $31 |
| Optos, Inc. | 2 | $27 |
| Smith+Nephew | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| Solventum Corporation | 1 | $20 |
| Ardelyx, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Reapplix Inc. | 1 | $16 |
| Mimedx Group, Inc. | 1 | $15 |
| Bioventus LLC | 1 | $12 |
| Phathom Pharmaceuticals, Inc. | 1 | $6 |
How this compares
$1,526 in reported general payments places this provider in the 40th percentile of 855 surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 67 | $4,522 |
| Vancomycin Hcl | 21 | $831 |
| Ciprofloxacin Hcl | 33 | $251 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $202 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 28 | $179 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $137 |
| Cephalexin | 22 | $104 |
Paid to pharmacies, not to this prescriber.
Other surgery in Bainbridge
- Idelberto BadellAtlanta$3.9M
- Chad CopperGainesville$999K
- Zachary KlaassenAugusta$763K
- Kendra GrubbAtlanta$761K
- Stephen OdomAustell$599K
- Fritz Jean-PierreMarietta$464K
- Nelson RoyallGainesville$415K
- Denise LoAtlanta$309K
- Christian LarsenAtlanta$308K
- Harry LightfootSmyrna$241K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.